Is Extracorporeal Membrane Oxygenator a New Weapon to Improve Prognosis in Patients With Profound Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention
In this review, we describe and interpret the potential role of circulatory mechanical support by extracorporeal membrane oxygenator (ECMO) in the setting of acute myocardial infarction (AMI) complicated by profound cardiogenic shock (CS) for improving clinical outcomes.
Options for Temporary Mechanical Circulatory Support
This review will examine the different options for commonly used temporary MCS devices including intra-aortic balloon pumps (IABPs), veno-arterial-extracorporeal membrane oxygenation (VA-ECMO), TandemHeart(®) (CardiacAssist, Pittsburg, PA, USA) Impella(®) and BVS 5000(®) (both Abiomed Inc., Danvers, MA, USA), CentriMag(®) and Thoratec percutaneous ventricular assist device (pVAD)(®) (both Thoratec Corporation, Pleasanton, CA, USA).
Lung Transplantation for Cystic Fibrosis
Lung transplantation is a viable option for many patients with cystic fibrosis (CF) and end-stage lung disease.
Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure
A 45-year-old male was admitted to our hospital with a small bowel obstruction due to torsion and was immediately scheduled for surgical intervention. At anesthesia induction, the patient aspirated and subsequently developed a severe SIRS with ARDS and multiple organ failure requiring the use of ECMO, CRRT, antibiotics, and low dose steroids
Review and Outcome of Prolonged Cardiopulmonary Resuscitation
The maximal duration of cardiopulmonary resuscitation (CPR) is unknown. We report a case of prolonged CPR. We have then reviewed all published cases with CPR duration equal to or more than 20 minutes. The objective was to determine the survival rate, the neurological outcome, and the characteristics of the survivors.
Advanced Mechanical Circulatory Support for Post-Cardiotomy Cardiogenic Shock: A 20-Year Outcome Analysis in a Non-Transplant Unit
Advanced mechanical circulatory support (AMCS) can be used to salvage carefully selected number of such patients. High costs and major complication rates have lead to centralization and limited funding for such devices in the UK. We have looked the outcomes of such devices in a non-transplant, intermediate-size adult cardiothoracic surgery unit.
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation
This study sought to investigate demographic, clinical, and procedural determinants of outcomes in patients treated with percutaneous veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) initiated in the cardiac catheterization laboratory with a portable system.
Transcatheter Closure of Post-Myocardial Infarction Ventricular Defect: Where Are We
Since 1988, Transcatheter closure of post-myocardial infarction ventricular defect became an alternative treatment for anatomically suitable patients with high risk of surgical closure.
Near Misses and Scary Possibilities (EP Video)
Dr. Lance Lester discusses is personal experiences with near misses and scary possibilities in surgery (56:00 minutes).
The Virtues and Pitfalls of Licensure (EP Video)
Mike Troike highlights the pros and cons of licensure, giving some historical perspective and ongoing developments that challenge the perfusion profession (44:19 minutes).
Newly Approved TAVR Valve Technology (EP Video)
Dr. Lee Lucas discusses the newly approved Sapien 3 and the CoreValve Evolut R (42:03 minutes).
Heart Failure in the Community Hospital (EP Video)
Dr. Neil Galindez discusses the trends in heart failure in the community hospital setting (28:22 minutes).